On Tuesday, Cathie Wood– led Ark Invest performed a substantial trade including Tempus AI Inc TEM
The Tempus AI Trade
Ark Invest’s choice to offer Tempus AI Inc TEM shares on Tuesday was performed through ARK Genomic Transformation ETF ARKG and ARK Development ETF ARKK ARKG unloaded 6,309 shares, while ARKK offered 19,627 shares. With the stock closing at $81.01, the overall worth of the shares offered totaled up to roughly $2.1 million.
See Likewise: UnitedHealth Group Unusual Options Activity For September 09
This relocation can be found in the wake of Tempus AI’s current acquisition of Paige, a business focusing on digital pathology, which had actually formerly driven the stock greater.
On The Other Hand, HC Wainwright cut its Tempus AI target to $90 however kept a Buy, while Morgan Stanley and BTIG kept Obese and Buy rankings with $68 and $85 targets, respectively, according to information from Benzinga Pro.
Other Secret Trades
- Prime Medication Inc (PRME): Ark Invest’s ARKG fund acquired 157,413 shares.
- Twist Bioscience Corp (TWST): The ARKG fund purchased 5,405 shares, while the ARKK fund obtained 42,327 shares.
Benzinga’s Edge Stock Rankings reveal that Tempus AI stock checks out on Short, Medium and Long Rate Patterns. Here is how the stock ranks on other metrics.
Read Next:
Picture: ChrisStock82/ Shutterstock
This story was created utilizing Benzinga Neuro and modified by Shivdeep Dhaliwal
Market News and Data gave you by Benzinga APIs